Log in
OTCMKTS:SGBI

Sangui Biotech International Stock Forecast, Price & News

$0.02
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.01
MA: $0.02
$0.04
52-Week Range
$0.01
Now: $0.02
$0.04
VolumeN/A
Average Volume10,821 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through Internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is based in Witten, Germany.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.66 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SGBI
CUSIPN/A
Phone+49-2302-915200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1
Next Earnings DateN/A
OptionableNot Optionable
$0.02
0.00 (0.00 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SGBI News and Ratings via Email

Sign-up to receive the latest news and ratings for SGBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sangui Biotech International (OTCMKTS:SGBI) Frequently Asked Questions

How has Sangui Biotech International's stock been impacted by COVID-19?

Sangui Biotech International's stock was trading at $0.0220 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SGBI stock has decreased by 27.7% and is now trading at $0.0159.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Sangui Biotech International?

Sangui Biotech International saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 600 shares, a decline of 62.5% from the August 15th total of 1,600 shares. Based on an average daily trading volume, of 2,900 shares, the short-interest ratio is presently 0.2 days.
View Sangui Biotech International's Short Interest
.

Who are some of Sangui Biotech International's key competitors?

Who are Sangui Biotech International's key executives?

Sangui Biotech International's management team includes the following people:
  • Mr. Thomas Striepe, CEO, Pres, CFO & Exec. Director (Age 55)

What is Sangui Biotech International's stock symbol?

Sangui Biotech International trades on the OTCMKTS under the ticker symbol "SGBI."

How do I buy shares of Sangui Biotech International?

Shares of SGBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sangui Biotech International's stock price today?

One share of SGBI stock can currently be purchased for approximately $0.02.

What is Sangui Biotech International's official website?

The official website for Sangui Biotech International is www.sanguibiotech.com.

How can I contact Sangui Biotech International?

Sangui Biotech International's mailing address is c/o SanguiBioTech GmbH Alfred-Herrhausen-Str. 44, WITTEN, UT 58455, Germany. The company can be reached via phone at +49-2302-915200.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.